Publikationen 2000

Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases
Maida M J, Daly C C, Hoffman I, Cohen M S, Kumwenda M, Vernazza P L
Eur J Epidemiol 2000;16:1183-1184

[abstract] [full-text/pdf]

 


Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)
Semela D, Glatz M, Hunziker D, Schmid U, Vernazza P L
SMW 2000;130:1726-1733

 

[abstract] [full-text/pdf]


Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study
Vernazza P L, Troiani L, Flepp M J, Cone R W, Schock J, Roth F, Boggian K, Cohen M S, Fiscus S A, Eron J J
AIDS 2000;14/2:117-121

[abstract] [full-text/pdf]


HIV superinfection: myth or reality?
Vernazza P L, Bernasconi E, Hirschel B
SMW 2000;130:1101-1104

[abstract] [full-text/pdf]


Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Rutschmann O T, Vernazza P L, Bucher H C, Opravil M, Ledergerber B, Telenti A, Malinverni R, Bernasconi E, Fagard C, Leduc D, Perrin L, Hirschel B
AIDS 2000;14 / 14:2145-2151

[abstract] [full-text/pdf]

 


Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women
Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD, Anzen B, van den Hoek A, Meier F, Pena JM, Savonius H, Sperandeo D, Suligoi B, Vernazza PL, Brunet JB
AIDS 2000;14 / 12:1775-1784

 

[abstract] [full-text/pdf]

 


Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen
Ping LH, Cohen MS, Hoffman I, Vernazza PL, Seillier-Moiseiwitsch F, Chakraborty H, Kazembe P, Zimba D, Maida M, Fiscus SA, Eron JJ, Swanstrom R, Nelson J A
J Virol 2000;74 / 19:8946-8952

 



Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments
Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza PL, Hall C, Cohen MS, Fiscus SA
J Clin Micro 2000;38/4:1414-1418



Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
Burgisser P, Vernazza PL, Flepp M, Boni J, Tomasik Z, Hummel U, Pantaleo G, Schupbach J
JAIDS 2000;23/2:138-145

[abstract] [full-text/pdf]


Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study
Opravil M, Cone RW, Fischer M, Vernazza PL, Bassetti S, Lorenzi P, Bisset LR, Ott P, Huber W, Knuchel MC, Roos M, Luthy R, Weber R
JAIDS 2000;23 / 1:17-25

[abstract] [full-text/pdf]


Sensitization to human immunodeficiency virus in seronegative exposed partners
Vernazza PL, Kahlert C, Fierz W
JID 2000;182:1810-1811



Todesursachen und Autopsiebefunde bei Patienten der Schweizerischen HIV-Kohortenstudie (SHCS)
D. Semela, M. Glatz, D. Hunziker, U. Schmid, P. L. Vernazza
Schweiz Med Wochenschr 2000;130:1726–33

[abstract]     [full-text/pdf]


Zweitinfektion mit HIV: Mythos oder Realität?
P. L. Vernazza, E. Bernasconi, B. Hirschel
Schweiz Med Wochenschr 2000;130:1101–4

[abstract]     [full-text/pdf]


Antiviral drugs
P. L. Vernazza